Clinical Trials Logo

Urinary Incontinence, Stress clinical trials

View clinical trials related to Urinary Incontinence, Stress.

Filter by:

NCT ID: NCT04636749 Recruiting - Clinical trials for Stress Urinary Incontinence

Erbium Vaginal Laser for the Treatment of Stress Urinary Incontinence

Start date: March 9, 2021
Phase: N/A
Study type: Interventional

Two arms of women who suffer from clinical stress urinary incontinence. Women will be divided randomly into two arms. One arm will be treated with vaginal Erbium laser and the second with Sham laser, three treatments each. Follow up will be done 6 and 12 months after the last treatment.

NCT ID: NCT04590157 Recruiting - Clinical trials for Stress Urinary Incontinence

Neuromodulation Effect of Laser Acupuncture on Stress Urinary Incontinence

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

background:Stress urinary incontinence (SUI) is the most common type of urinary incontinence in women, as it involves involuntary leakage of urine , the current study was To determine the neuromodulation effect of Laser Therapy on Neurogenic Acupoints in female with stress urinary incontinence (SUI).

NCT ID: NCT04590092 Recruiting - Pregnancy Related Clinical Trials

Pessary Use for Stress Urinary Incontinence in Pregnancy

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

When women are pregnant they are more likely to leak urine which can severely affect their quality of life. This problem could be fixed by using a pessary. A pessary is a silicone ring that goes into the vagina which can stop or improve urinary leakage. These devices have been safely used for hundreds of years. However, pessaries has not been studied for urinary leakage in pregnancy. The investigators would like to compare severity of urinary leakage using a number of questionnaires during the last 3 months of pregnancy for women using a pessary versus women without a pessary.

NCT ID: NCT04586166 Recruiting - Clinical trials for Stress Urinary Incontinence

Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy

SASS
Start date: December 23, 2020
Phase: N/A
Study type: Interventional

SASS (Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy) will be a multicenter, prospective, randomized, single-blind non-inferiority trial.

NCT ID: NCT04465578 Recruiting - Clinical trials for Stress Urinary Incontinence

Incidence of Short-term Urinary Retention After Fascial Retropubic Sling: Prospective and Randomized Analysis.

Start date: February 10, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the incidence of short-term urinary retention and the cure rate in patients with stress urinary incontinence undergoing surgical treatment with fascial pubovaginal sling with two tension adjustment techniques: the classic adjustment technique ("2 fingers") and measuring the distance between the fixation knot and the aponeurosis of 4 cm.

NCT ID: NCT04429360 Recruiting - Overactive Bladder Clinical Trials

What is the Effect of Prolapse Surgery on Voiding?

PROVOID
Start date: June 8, 2020
Phase:
Study type: Observational

The aim of our study is to examine the effect of prolapse surgery on voiding. Our study is the very first one to combine several innovative low-invasive and low-cost methods to analyse the amelioration or deterioration of voiding function after surgery for pelvic organ prolapse using 3D/4D translabial ultrasound, home-uroflowmetry and patient reported quality of life outcomes.

NCT ID: NCT04361890 Recruiting - Ultrasound Clinical Trials

Ultrasound and Pelvic Floor Muscle Training

ERP
Start date: January 7, 2020
Phase: N/A
Study type: Interventional

The objective is to validate the use of ultrasound measurements (urethral mobility, movement of the ano-rectal angle, elastography measurements) in women with urinary incontiennce before and after pelvic floor muscle training (PFMT) : inter and intra-observer reproducibility; correlation with clinical examination (modified Oxford scale); sensitivity to change before/after pelvic floor muscle training

NCT ID: NCT04307680 Recruiting - Clinical trials for Stress Urinary Incontinence

Evaluation and Comparison of Efficacy Between Extracorporeal Magnetic Innervation and High-intensity Kegel Exercise Regimen in Treatment of Stress Urinary Incontinence in Female

KEMS-CRO
Start date: August 2, 2020
Phase: N/A
Study type: Interventional

The aim of this prospective, randomized controlled study is to evaluate and compare efficacy between the most available conservative treatment (magnetic stimulation and Kegel exercise) for stress urinary incontinence in Croatia. We will assess quality-of-life, patient global improvement, and vaginal pressure measured with perineometer in three different time points: at the enrollment, after 8 weeks of treatment and 3 months after the both treatments are done.

NCT ID: NCT04248283 Recruiting - Clinical trials for Urinary Incontinence

Adjustable Continence Therapy (ACT) for the Treatment of Female SUI

Start date: January 26, 2021
Phase: N/A
Study type: Interventional

A prospective, single arm, non-randomized, multicenter, prospective case-series trial. The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.

NCT ID: NCT04144829 Recruiting - Clinical trials for Stress Urinary Incontinence

Platelet-rich Fibrin Versus HIFU in Management of Stress Urinary Incontinence

Start date: August 1, 2019
Phase: N/A
Study type: Interventional

Aim of the study is to compare effect of High Intensity Focused Ultrasound (HIFU) and platelet-rich fibrin in management of stress urinary incontinence. It is a randomized prospective study. After assigning to one of the two groups, patients will undergo relevant treatment. First group will undergo 3 cycles of intravaginal HIFU treatment in 6-weeks interval. Second group will undergo 3 injections of platelet-rich fibrin under urethra. Before the treatment and after 2, 6 and 12 months after treatment is finished patients will be asked to fill questionaries concerning quality of life ICIQ-UI SF, ICIQ-LUTS, PISQ12, FSFI. Before each treatment cycle patients will be examined and asked to fill daily micturition plan.